Point‐of‐care biomarkers in asthma management: Time to move forward.

Point-of-care biomarkers in asthma management: Time to move forward In this capacity, they complement symptom scoring and lung function measurement in asthma management. The conclusions were to recommend FeNO measurement and spirometry to be used as initial assessments in all patients in whom asthma is suspected and propose FeNO measurement to be considered in the management of patients with asthma who remain symptomatic despite inhaled corticosteroid treatment. [Extracted from the article]